Quick Takeaways
- Alyeska Investment Group, L.P. filed SCHEDULE 13G/A for Immunic, Inc. Common Stock, $0.0001 par value (IMUX).
- Disclosed ownership: 6.2%.
- Date of event: 31 Dec 2025.
Alyeska Investment Group, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Immunic, Inc. Common Stock, $0.0001 par value (IMUX)
- Filing Manager
- Alyeska Investment Group, L.P.
- Reporting Manager
- Alyeska Investment Group, L.P.
- Symbol
- IMUX
- Shares outstanding
- 120,192,308 shares
- Disclosed Ownership
- 7,500,000 shares
- Ownership
- 6.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:41:29 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Alyeska Investment Group, L.P. disclosed 6.2% ownership in Immunic, Inc. Common Stock, $0.0001 par value (IMUX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 16:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 6.2% | 7,500,000 | 0 | 7,500,000 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Alyeska Fund GP, LLC | 6.2% | 7,500,000 | 0 | 7,500,000 | Jason Bragg | Jason Bragg | Chief Financial Officer | |
| Anand Parekh | 6.2% | 7,500,000 | 0 | 7,500,000 | Anand Parekh | Anand Parekh | Self |